157 related articles for article (PubMed ID: 37899129)
21. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.
Kumar S; Metz DC; Ellenberg S; Kaplan DE; Goldberg DS
Gastroenterology; 2020 Feb; 158(3):527-536.e7. PubMed ID: 31654635
[TBL] [Abstract][Full Text] [Related]
22. Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
Kim YI; Cho SJ; Lee JY; Kim CG; Kook MC; Ryu KW; Kim YW; Choi IJ
Cancer Res Treat; 2016 Jul; 48(3):1020-9. PubMed ID: 26582396
[TBL] [Abstract][Full Text] [Related]
23. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
24. The effect of Helicobacter pylori eradication on prognosis of postoperative early gastric cancer: a multicenter study.
Wang L; Wang J; Li S; Bai F; Xie H; Shan H; Liu Z; Ma T; Tang X; Tang H; Qin A; Lei S; Zuo C
World J Surg Oncol; 2021 Sep; 19(1):285. PubMed ID: 34548086
[TBL] [Abstract][Full Text] [Related]
25. The prognostic role of Helicobacter pylori in gastric cancer patients: A meta-analysis.
Li G; Yu S; Xu J; Zhang X; Ye J; Wang Z; He Y
Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):216-224. PubMed ID: 30361060
[TBL] [Abstract][Full Text] [Related]
26. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
[TBL] [Abstract][Full Text] [Related]
28. Effect of
Guo Y; Zhang Y; Gerhard M; Gao JJ; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF
Gut; 2020 Sep; 69(9):1598-1607. PubMed ID: 31857433
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and Helicobacter pylori status of gastric cancer in Thailand.
Vilaichone RK; Panarat W; Aekpongpaisit S; Mahachai V
Asian Pac J Cancer Prev; 2014; 15(20):9005-8. PubMed ID: 25374243
[TBL] [Abstract][Full Text] [Related]
30. Family History of Gastric Cancer and
Choi IJ; Kim CG; Lee JY; Kim YI; Kook MC; Park B; Joo J
N Engl J Med; 2020 Jan; 382(5):427-436. PubMed ID: 31995688
[TBL] [Abstract][Full Text] [Related]
31. Effect of Helicobacter pylori on immunotherapy is gaining more attention.
Shi Y; Zheng H; Guo Z; Deng R; Yu W; Song Y; Ding S
Helicobacter; 2022 Oct; 27(5):e12925. PubMed ID: 36036113
[TBL] [Abstract][Full Text] [Related]
32. Adverse impact of bone metastases on clinical outcomes of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
Li X; Wang L; Chen S; Zhou F; Zhao J; Zhao W; Su C
Thorac Cancer; 2020 Oct; 11(10):2812-2819. PubMed ID: 32779372
[TBL] [Abstract][Full Text] [Related]
33. Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors.
Giordan Q; Salleron J; Vallance C; Moriana C; Clement-Duchene C
Front Immunol; 2021; 12():716317. PubMed ID: 34777340
[TBL] [Abstract][Full Text] [Related]
34. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention.
Shi Y; Zheng H; Wang M; Ding S
Helicobacter; 2022 Apr; 27(2):e12878. PubMed ID: 35112435
[TBL] [Abstract][Full Text] [Related]
35. The interplay between
Fakharian F; Asgari B; Nabavi-Rad A; Sadeghi A; Soleimani N; Yadegar A; Zali MR
Front Cell Infect Microbiol; 2022; 12():953718. PubMed ID: 36046747
[TBL] [Abstract][Full Text] [Related]
36. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
37. Is It a Protective Factor of Helicobacter pylori Infection in Overall Survival of All Gastric Cancer? Evidence from Meta-Analysis.
Zheng F; Sun Z; Kan J; Yin J; Du F; Shen G; Wang Z; Ren D; Bao X; Zhao J
J Environ Pathol Toxicol Oncol; 2017; 36(4):309-320. PubMed ID: 29431063
[TBL] [Abstract][Full Text] [Related]
38. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
39. Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers.
Kim HJ; Kim N; Yoon H; Choi YJ; Lee JY; Kwon YH; Yoon K; Jo HJ; Shin CM; Park YS; Park DJ; Kim HH; Lee HS; Lee DH
Gut Liver; 2016 Mar; 10(2):212-9. PubMed ID: 26087794
[TBL] [Abstract][Full Text] [Related]
40. Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer.
Toyoda T; Tsukamoto T; Yamamoto M; Ban H; Saito N; Takasu S; Shi L; Saito A; Ito S; Yamamura Y; Nishikawa A; Ogawa K; Tanaka T; Tatematsu M
BMC Gastroenterol; 2013 Jul; 13():122. PubMed ID: 23899160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
